Lnc-PKNOX1-1 inhibits tumor progression in cutaneous malignant melanoma by regulating NF-κB/IL-8 axis
Carcinogenesis · 2023
DOI: 10.1093/carcin/bgad073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2023. Verfasst von Anlan Hong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China. Hauptthemen laut MEDLINE: Melanoma, RNA, Long Noncoding, Skin Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Cutaneous malignant melanoma is one of the most lethal cutaneous malignancies. Accumulating evidence has demonstrated the potential influence of long non-coding RNAs (lncRNAs) in biological behaviors of melanoma. Herein, we reported a novel lncRNA, lnc-PKNOX1-1 and systematically studied its functions and possible molecular mechanisms in melanoma. Reverse transcription-quantitative PCR assay showed that lnc-PKNOX1-1 was significantly decreased in melanoma cells and tissues. Low lnc-PKNOX1-1 expression was significantly correlated with invasive pathological type and Breslow thickness of melanoma. In vitro and in vivo experiments showed lnc-PKNOX1-1 dramatically inhibited melanoma cell proliferation, migration and invasion. Mechanically, protein microarray analysis suggested that interleukin-8 (IL-8) was negatively regulated by lnc-PKNOX1-1 in melanoma, which was confirmed by western blot and ELISA. Western blot analysis also showed that lnc-PKNOX1-1 could promote p65 phosphorylation at Ser536 in melanoma. Subsequent rescue assays proved IL-8 overexpression could partly reverse the tumor-suppressing function of lnc-PKNOX1-1 overexpression in melanoma cells, indicating that lnc-PKNOX1-1 suppressed the development of melanoma by regulating IL-8. Taken together, our study demonstrated the tumor-suppressing ability of lnc-PKNOX1-1 in melanoma, suggesting its potential as a novel diagnostic biomarker and therapeutic target for melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China.
- Department of Dermatology, the First Hospital of Hebei Medical University, Shijiazhuang, China.
ORCID-Profile: Anlan Hong
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Hong, A., Cao, M., Li, D., Wang, Y., Zhang, G., Fang, F., Zhao, L., Wang, Q., Lin, T., & Wang, Y. (2023). Lnc-PKNOX1-1 inhibits tumor progression in cutaneous malignant melanoma by regulating NF-κB/IL-8 axis. Carcinogenesis. https://doi.org/10.1093/carcin/bgad073
Vancouver
Hong A, Cao M, Li D, Wang Y, Zhang G, Fang F, et al. Lnc-PKNOX1-1 inhibits tumor progression in cutaneous malignant melanoma by regulating NF-κB/IL-8 axis. Carcinogenesis. 2023. doi:10.1093/carcin/bgad073
BibTeX
@article{Hong2023,
author = {Hong, Anlan and Cao, Meng and Li, Dongqing and Wang, Yixin and Zhang, Guoqiang and Fang, Fang and Zhao, Liang and Wang, Qiang and Lin, Tong and Wang, Yan},
title = {Lnc-PKNOX1-1 inhibits tumor progression in cutaneous malignant melanoma by regulating NF-κB/IL-8 axis},
journal = {Carcinogenesis},
year = {2023},
doi = {10.1093/carcin/bgad073}
}
EUVIMED